Literature DB >> 3958379

Myocardial mechanics in hyperthyroidism: importance of left ventricular loading conditions, heart rate and contractile state.

T Feldman, K M Borow, D H Sarne, A Neumann, R M Lang.   

Abstract

Hyperthyroidism has been reported to affect all of the major determinants of left ventricular performance in a manner that would augment ventricular shortening characteristics. The hypothesis tested in this study is that reduced afterload in conjunction with increased preload and heart rate, rather than augmented contractility, accounts for much of the increase in left ventricular performance noted previously in these patients. To investigate this hypothesis, 11 hyperthyroid patients were evaluated serially over 4 +/- 2 months. With therapy, serum total thyroxin (T4) decreased significantly (p less than 0.001). Ventricular hemodynamics were assessed by two-dimensional targeted M-mode echocardiograms and calibrated carotid pulse tracings. Ventricular preload was estimated by end-diastolic dimension, whereas afterload was measured as end-systolic wall stress. Overall left ventricular performance was quantitated by the extent and velocity of shortening, whereas myocardial work was assessed by ventricular systolic stress-length relations. With therapy, overall left ventricular performance declined (p less than 0.01). This change was associated with no change in end-diastolic dimension or end-systolic wall stress, and a 24% fall in heart rate (p less than 0.01). This latter finding has been shown previously to have no significant effect on left ventricular contractile state over the range of heart rates encountered in this study. In all cases, the end-systolic stress/rate-corrected shortening velocity relation fell with attainment of normal thyroid status, characteristic of a decline in contractility. There was a strong positive correlation between left ventricular contractility and serum thyroid hormone level (r = 0.83). In addition, ventricular minute work declined with therapy (p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1986        PMID: 3958379     DOI: 10.1016/s0735-1097(86)80213-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  17 in total

1.  Triiodothyronine induces over-expression of alpha-smooth muscle actin, restricts myofibrillar expansion and is permissive for the action of basic fibroblast growth factor and insulin-like growth factor I in adult rat cardiomyocytes.

Authors:  M A Gosteli-Peter; B A Harder; H M Eppenberger; J Zapf; M C Schaub
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

2.  Thyroid function and left ventricular structure and function in the Framingham Heart Study.

Authors:  Elizabeth N Pearce; Qiong Yang; Emelia J Benjamin; Jayashri Aragam; Ramachandran S Vasan
Journal:  Thyroid       Date:  2010-04       Impact factor: 6.568

3.  Heart rate reduction with ivabradine prevents thyroid hormone-induced cardiac remodeling in rat.

Authors:  Bo Hyun Kim; Kyoung Im Cho; Seong Man Kim; Nari Kim; Jin Han; Jee Yeon Kim; In Ju Kim
Journal:  Heart Vessels       Date:  2012-11-11       Impact factor: 2.037

4.  Gene polymorphisms and thyroid function in patients with heart failure.

Authors:  Ioannis Vasiliadis; Genovefa Kolovou; Vana Kolovou; Vasiliki Giannakopoulou; Maria Boutsikou; Niki Katsiki; Evaggelia Papadopoulou; Sophie Mavrogeni; Konstantina Sorontila; Costas Pantos; Dennis V Cokkinos
Journal:  Endocrine       Date:  2013-03-30       Impact factor: 3.633

5.  Dyspnoea of cardiac origin in 67 year old men: (1). Relation to systolic left ventricular function and wall stress. The study of men born in 1913.

Authors:  K Caidahl; H Eriksson; M Hartford; J Wikstrand; I Wallentin; K Svärdsudd
Journal:  Br Heart J       Date:  1988-03

6.  Thyroid and Cardiovascular Disease: Research Agenda for Enhancing Knowledge, Prevention, and Treatment.

Authors:  Anne R Cappola; Akshay S Desai; Marco Medici; Lawton S Cooper; Debra Egan; George Sopko; Glenn I Fishman; Steven Goldman; David S Cooper; Samia Mora; Peter J Kudenchuk; Anthony N Hollenberg; Cheryl L McDonald; Paul W Ladenson
Journal:  Thyroid       Date:  2019-05-13       Impact factor: 6.568

7.  Thyroid and Cardiovascular Disease Research Agenda for Enhancing Knowledge, Prevention, and Treatment.

Authors:  Anne R Cappola; Akshay S Desai; Marco Medici; Lawton S Cooper; Debra Egan; George Sopko; Glenn I Fishman; Steven Goldman; David S Cooper; Samia Mora; Peter J Kudenchuk; Anthony N Hollenberg; Cheryl L McDonald; Paul W Ladenson
Journal:  Circulation       Date:  2019-05-13       Impact factor: 29.690

8.  Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis.

Authors:  G W Ching; J A Franklyn; T J Stallard; J Daykin; M C Sheppard; M D Gammage
Journal:  Heart       Date:  1996-04       Impact factor: 5.994

9.  Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism.

Authors:  Chung-Wah Siu; Chun-Yip Yeung; Chu-Pak Lau; Annie W C Kung; Hung-Fat Tse
Journal:  Heart       Date:  2006-09-27       Impact factor: 5.994

Review 10.  [Angina pectoris in extracoronary diseases].

Authors:  A Wilke; B Noll; B Maisch
Journal:  Herz       Date:  1999-04       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.